Letter to the Editor

On “Predictors of Blood Transfusion in Patients Undergoing Cytoreductive Surgeries for Ovarian Malignancy”

Authors: Jana K. Elsawwah, BA, Patricia B. Stopper, APN-C, Zoltan H. Nemeth, MD, PhD

Abstract

To the Editor: We appreciate the work of Pearce et al regarding the predictors of perioperative blood transfusion in patients undergoing cytoreductive surgery for ovarian cancer.1 They found that patients with lower preoperative hemoglobin and higher intraoperative estimated blood loss (EBL) were at greater risk of needing a blood transfusion. Blood transfusions confer an increased risk of complications, including venous thromboembolisms, cancer recurrence, and mortality.1
Posted in: Gynecologic Cancer8

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Pearce JV, Zhao J, Randall L, et al. Predictors of blood transfusion in patients undergoing cytoreductive surgeries for ovarian malignancy. South Med J 2024;117:266–271.
 
2. Alrobaiq BM, Alharbi RS, Alhoshan FS, et al. Hypertension and ovarian cancer: a case-control study in Saudi Arabia. Cureus 2023;15:e35294.
 
3. Gill R, Goldstein S. Evaluation and Management of Perioperative Hypertension. Treasure Island, FL: StatPearls Publishing; 2024.
 
4. Shinn EH, Lenihan DJ, Urbauer DL, et al. Impact of cardiovascular comorbidity on ovarian cancer mortality. Cancer Epidemiol Biomarkers Prev 2013;22:2102–2109.
 
5. Chotisukarat H, Akavipat P, Suchartwatnachai P, et al. Incidence and risk factors for perioperative cardiovascular complications in spine surgery. F1000Res 2022;11:15.